{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:11:51Z","timestamp":1791180711158,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.arcmed.2006.09.001","type":"journal-article","created":{"date-parts":[[2007,7,5]],"date-time":"2007-07-05T14:07:41Z","timestamp":1183644461000},"page":"621-627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Hepatitis C and Steatosis"],"prefix":"10.1016","volume":"38","author":[{"given":"Einar","family":"Bj\u00f6rnsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Angulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2006.09.001_bib1","unstructured":"Perz JF, Farrington LA, Pecoraro C, Hutin YJF, Armstrong GL. Estimated global prevalence of hepatitis C virus infection. 42nd Annual Meeting of the Infectious Diseases Society of America: Boston, MA; 2004."},{"key":"10.1016\/j.arcmed.2006.09.001_bib2","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2006.09.001_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1055\/s-2004-860869","article-title":"Hepatitis C and nonalcoholic fatty liver disease","volume":"24","author":"Ramesh","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.arcmed.2006.09.001_bib4","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2003.11.020","article-title":"Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease","volume":"126","author":"Lonardo","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib5","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/hep.21239","article-title":"Impact of obesity on treatment of chronic hepatitis C","volume":"43","author":"Charlton","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.2005.069757","article-title":"Steatosis in chronic hepatitis C: why does it really matter?","volume":"55","author":"Asselah","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2006.09.001_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2893.2005.00669.x","article-title":"Hepatitis C and steatosis: a reappraisal","volume":"13","author":"Lonardo","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.arcmed.2006.09.001_bib8","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.gastro.2006.03.014","article-title":"HCV Meta-Analysis (on) Individual Patients' Data Study Group. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data","volume":"130","author":"Leandro","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.arcmed.2006.09.001_bib10","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/jcem.84.5.5661","article-title":"Liver pathology and the metabolic syndrome X in severe obesity","volume":"84","author":"Marceau","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2006.09.001_bib11","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.arcmed.2006.09.001_bib12","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1080\/00365520410006431","article-title":"High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease","volume":"39","author":"Friis-Liby","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib13","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib14","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/jlts.2002.36740","article-title":"One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation","volume":"8","author":"Ryan","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.001_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2005.02.042","article-title":"Prevalence of and risk factors for fatty liver in a general population of Shanghai, China","volume":"43","author":"Fan","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2169\/internalmedicine1962.27.142","article-title":"Prevalence of fatty liver in a general population of Okinawa, Japan","volume":"27","author":"Nomura","year":"1988","journal-title":"Jpn J Med"},{"key":"10.1016\/j.arcmed.2006.09.001_bib18","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0016-5085(03)00395-0","article-title":"Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States","volume":"124","author":"Ruhl","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/00365528609034632","article-title":"Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases","volume":"21","author":"Hultcrantz","year":"1986","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/00365529950172880","article-title":"The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients","volume":"34","author":"Mathiesen","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib21","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1111\/j.1572-0241.1999.01451.x","article-title":"Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients","volume":"94","author":"Daniel","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001","volume":"289","author":"Mokdad","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.arcmed.2006.09.001_bib23","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.2337\/diacare.27.10.2444","article-title":"Increasing prevalence of the metabolic syndrome among U.S","volume":"27","author":"Ford","year":"2004","journal-title":"Adults. Diabetes Care"},{"key":"10.1016\/j.arcmed.2006.09.001_bib24","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/hep.510300625","article-title":"Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients","volume":"30","author":"Adinolfi","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00042737-199602000-00006","article-title":"Liver steatosis and chronic hepatitis C: a spurious association?","volume":"8","author":"Fiore","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0168-8278(98)80004-4","article-title":"Host- and disease-specific factors affecting steatosis in chronic hepatitis C","volume":"29","author":"Czaja","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib27","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.510290401","article-title":"Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis","volume":"29","author":"Hourigan","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib28","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0168-8278(00)00096-9","article-title":"Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation","volume":"34","author":"Clouston","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1440-1746.2001.02407.x","article-title":"Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation","volume":"16","author":"Hwang","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib30","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/jhep.2001.24432","article-title":"Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity","volume":"33","author":"Adinolfi","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib31","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1572-0241.2003.07402.x","article-title":"Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis","volume":"98","author":"Petit","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib32","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1053\/jhep.2002.35064","article-title":"Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol","volume":"36","author":"Monto","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/jhep.2003.50267","article-title":"Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C","volume":"38","author":"Poynard","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-8278(03)00479-3","article-title":"Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States","volume":"40","author":"Hu","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/gut.2003.018770","article-title":"Steatosis affects chronic hepatitis C progression in a genotype specific way","volume":"53","author":"Rubbia-Brandt","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2006.09.001_bib36","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jhep.2003.11.004","article-title":"The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients","volume":"40","author":"Patton","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-2007-1007264","article-title":"Histopathology of hepatitis C virus infection","volume":"15","author":"Goodman","year":"1995","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.arcmed.2006.09.001_bib38","first-page":"40","article-title":"Hepatitis C and steatosis","volume":"13","author":"Monto","year":"2002","journal-title":"Semin Gastrointest Dis"},{"key":"10.1016\/j.arcmed.2006.09.001_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00042737-200603000-00002","article-title":"Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis","volume":"18","author":"Thomopoulos","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib40","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1053\/j.gastro.2003.08.032","article-title":"Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression","volume":"125","author":"Hui","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib41","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1572-0241.2003.07450.x","article-title":"Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C","volume":"98","author":"Romero-Gomez","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib42","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1111\/j.1572-0241.2002.05995.x","article-title":"Contribution of obesity to hepatitis C-related fibrosis progression","volume":"97","author":"Ortiz","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib43","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1046\/j.1440-1746.2002.02813.x","article-title":"Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection","volume":"17","author":"Hui","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib44","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0168-8278(02)00299-4","article-title":"Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients","volume":"37","author":"Westin","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib45","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1053\/jhep.2002.36370","article-title":"Hepatitis C virus genotype 3 is cytopathic to hepatocytes: reversal of hepatic steatosis after sustained therapeutic response","volume":"36","author":"Kumar","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib46","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0168-8278(00)80166-X","article-title":"Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3","volume":"33","author":"Rubbia-Brandt","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib47","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.52.2.288","article-title":"Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies","volume":"52","author":"Castera","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2006.09.001_bib48","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1099\/0022-1317-78-7-1527","article-title":"Hepatitis C virus core protein induces hepatic steatosis in transgenic mice","volume":"78","author":"Moriya","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib49","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/2053","article-title":"The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice","volume":"4","author":"Moriya","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.arcmed.2006.09.001_bib50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1096\/fj.01-0396com","article-title":"Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis","volume":"16","author":"Perlemuter","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.arcmed.2006.09.001_bib51","doi-asserted-by":"crossref","unstructured":"Abid K, Pazienza V, de Gottardi A, Rubbia-Brandt L, Conne B, Pugnale P, et\u00a0al. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation. J Hepatol 200;42:744\u2013751.","DOI":"10.1016\/j.jhep.2004.12.034"},{"key":"10.1016\/j.arcmed.2006.09.001_bib52","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0168-8278(05)80631-2","article-title":"Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population","volume":"21","author":"Allison","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib53","first-page":"526","article-title":"Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection","volume":"32","author":"Fraser","year":"1996","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.arcmed.2006.09.001_bib54","first-page":"1480","article-title":"Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection","volume":"91","author":"Ozyilkan","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib55","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4065\/75.4.355","article-title":"Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection","volume":"75","author":"Knobler","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.arcmed.2006.09.001_bib56","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States","volume":"133","author":"Mehta","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arcmed.2006.09.001_bib57","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1572-0241.2005.40429.x","article-title":"Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study","volume":"100","author":"Zein","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib58","first-page":"438","article-title":"Association between hepatitis C, diabetes mellitus, and race. a case-control study","volume":"98","author":"Thuluvath","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11894-004-0022-5","article-title":"Fat, diabetes, and liver injury in chronic hepatitis C","volume":"6","author":"Ratziu","year":"2004","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.arcmed.2006.09.001_bib60","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.mcg.0000190774.91875.d2","article-title":"Liver disease in patients with diabetes mellitus","volume":"40","author":"Harrison","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib61","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/gut.2003.026393","article-title":"Fibrosis progression in chronic hepatitis C virus infection","volume":"53","author":"McCaughan","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2006.09.001_bib62","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.510290235","article-title":"Association of diabetes mellitus and chronic hepatitis C virus infection","volume":"29","author":"Mason","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib63","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/hep.510300416","article-title":"Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection","volume":"30","author":"Caronia","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib64","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/aje\/kwg259","article-title":"Community-based study of hepatitis C virus infection and type 2 diabetes: an association affected by age and hepatitis severity status","volume":"158","author":"Wang","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib65","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2003.11.056","article-title":"Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance","volume":"126","author":"Shintani","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib66","first-page":"210","article-title":"Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C","volume":"23","author":"Larrea","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib67","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1365-2893.2002.00343.x","article-title":"Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis","volume":"9","author":"Neuman","year":"2002","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.arcmed.2006.09.001_bib68","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","article-title":"Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function","volume":"389","author":"Uysal","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2006.09.001_bib69","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2337\/diabetes.50.5.1102","article-title":"Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells","volume":"50","author":"Halse","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.arcmed.2006.09.001_bib70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2362.2000.00608.x","article-title":"Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha","volume":"30","author":"Konrad","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.arcmed.2006.09.001_bib71","first-page":"335","article-title":"Changes in glucose tolerance after interferon-alpha therapy in patients with chronic hepatitis C","volume":"28","author":"Tanaka","year":"1997","journal-title":"J Med"},{"key":"10.1016\/j.arcmed.2006.09.001_bib72","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.gastro.2004.12.049","article-title":"Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in\u00a0chronic hepatitis C patients","volume":"128","author":"Romero-Gomez","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib73","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/gut.2004.050302","article-title":"Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C","volume":"54","author":"Fartoux","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2006.09.001_bib74","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/jhep.2001.28055","article-title":"High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis","volume":"34","author":"Paradis","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib75","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.gastro.2006.03.014","article-title":"Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data","volume":"130","author":"Leandro","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib76","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/hep.20179","article-title":"Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury","volume":"39","author":"Walsh","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib77","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2006.09.001_bib78","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0168-8278(03)00456-2","article-title":"Fibrogenic impact of high serum glucose in chronic hepatitis C","volume":"39","author":"Ratziu","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib79","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0168-8278(03)00463-X","article-title":"In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy","volume":"39","author":"Hickman","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib80","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/gast.2003.50018","article-title":"Progression of fibrosis in chronic hepatitis C","volume":"124","author":"Ghany","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib81","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/gut.2003.021691","article-title":"Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study","volume":"53","author":"Ryder","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2006.09.001_bib82","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2559.1998.00413.x","article-title":"Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C","volume":"32","author":"Kaserer","year":"1998","journal-title":"Histopathology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib83","first-page":"569A","article-title":"Liver steatosis and response to interferon-alpha in patients with a chronic hepatitis C","volume":"28","author":"Wedemeyer","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib84","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1136\/gut.34.12.1714","article-title":"Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables","volume":"34","author":"Camps","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2006.09.001_bib85","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2006.09.001_bib86","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2006.09.001_bib87","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/003655202317284264","article-title":"Effect of interferon-alpha induction therapy on genotype 2b\/3a and low viral load hepatitis C virus infection. A randomized multicentre study","volume":"37","author":"Bjoro","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib88","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0168-8278(02)00301-X","article-title":"Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors","volume":"37","author":"Akuta","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib89","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2004.02.007","article-title":"Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3","volume":"40","author":"Zeuzem","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib90","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/jhep.2003.50350","article-title":"High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C","volume":"38","author":"Bressler","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib91","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S1542-3565(05)00246-6","article-title":"Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C","volume":"3","author":"Harrison","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib92","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1053\/jhep.2003.50413","article-title":"Obesity and its nurturing effect on hepatitis C","volume":"38","author":"McCullough","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib93","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJM200012073432301","article-title":"Peginterferon alfa-2a in patients with chronic hepatitis C","volume":"343","author":"Zeuzem","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2006.09.001_bib94","first-page":"268","article-title":"Obesity predisposes to increased drainage following axillary node clearance: a prospective audit","volume":"83","author":"Banerjee","year":"2001","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.arcmed.2006.09.001_bib95","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1023\/A:1018865928308","article-title":"Effect of obesity on pharmacokinetics and biologic effect of interferon-alpha in hepatitis C","volume":"42","author":"Lam","year":"1997","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.arcmed.2006.09.001_bib96","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/hep.1840210646","article-title":"Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosis","volume":"21","author":"Taliani","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.001_bib97","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0168-8278(01)00107-6","article-title":"Steatosis in chronic hepatitis C: can weight reduction improve therapeutic efficacy?","volume":"35","author":"Giannini","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.001_bib98","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/gut.51.1.89","article-title":"Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C","volume":"51","author":"Hickman","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2006.09.001_bib99","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/gut.2003.027581","article-title":"Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life","volume":"53","author":"Hickman","year":"2004","journal-title":"Gut"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440906003067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440906003067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:33:19Z","timestamp":1759260799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440906003067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0188440906003067"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2006.09.001","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C and Steatosis","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2006.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}